Cargando…

EXPERIMENTAL STUDY OF A HORSE ANTIPOLIOMYELITIC SERUM

Through the kindness of Dr. W. H. Park we have been enabled to study a horse antipoliomyelitic serum. This preparation has been supplied us in three forms: citrated blood plasma, serum, and globulin concentrate. We have tested these preparations in vitro and in vivo for inactivating or neutralizing...

Descripción completa

Detalles Bibliográficos
Autor principal: Rhoads, C. P.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1931
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2131941/
https://www.ncbi.nlm.nih.gov/pubmed/19869822
_version_ 1782142330805944320
author Rhoads, C. P.
author_facet Rhoads, C. P.
author_sort Rhoads, C. P.
collection PubMed
description Through the kindness of Dr. W. H. Park we have been enabled to study a horse antipoliomyelitic serum. This preparation has been supplied us in three forms: citrated blood plasma, serum, and globulin concentrate. We have tested these preparations in vitro and in vivo for inactivating or neutralizing or, to use perhaps a better term, antiviral effects against a constant, potent, filtrate virus of poliomyelitis. The preparations exhibited these effects when combined in vitro. Their action in this respect appears to be greater and more constant than that found by Stewart and Haselbauer for the Pettit antipoliomyelitic horse serum. On the other hand, in vivo tests carried out by us were less successful. In comparison with the constancy of action, under given conditions, of convalescent monkey and human sera, the antipoliomyelitic horse serum displayed striking irregularity, and certain preparations were devoid of protective power. The precise nature of the inactivating substances in the horse antiserum and their relation to the corresponding substances in convalescent sera have still, to be determined. As far as one absorption test carried out by us indicates, precipitin does not play a major rôle in the inactivating process. When an active globulin concentrate was filtered through Berkefeld candles, it lost its in vitro inactivating power. This is not true of convalescent sera in the native state. No tests have, however, been made with globulin concentrates from such sera. The experiments described in this paper raise the question whether, therapeutically considered, the antipoliomyelitic horse serum should be regarded as an exact equivalent of, and hence employed as a perfect substitute for, convalescent serum. This question can only be answered by further experiment and observation.
format Text
id pubmed-2131941
institution National Center for Biotechnology Information
language English
publishDate 1931
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21319412008-04-18 EXPERIMENTAL STUDY OF A HORSE ANTIPOLIOMYELITIC SERUM Rhoads, C. P. J Exp Med Article Through the kindness of Dr. W. H. Park we have been enabled to study a horse antipoliomyelitic serum. This preparation has been supplied us in three forms: citrated blood plasma, serum, and globulin concentrate. We have tested these preparations in vitro and in vivo for inactivating or neutralizing or, to use perhaps a better term, antiviral effects against a constant, potent, filtrate virus of poliomyelitis. The preparations exhibited these effects when combined in vitro. Their action in this respect appears to be greater and more constant than that found by Stewart and Haselbauer for the Pettit antipoliomyelitic horse serum. On the other hand, in vivo tests carried out by us were less successful. In comparison with the constancy of action, under given conditions, of convalescent monkey and human sera, the antipoliomyelitic horse serum displayed striking irregularity, and certain preparations were devoid of protective power. The precise nature of the inactivating substances in the horse antiserum and their relation to the corresponding substances in convalescent sera have still, to be determined. As far as one absorption test carried out by us indicates, precipitin does not play a major rôle in the inactivating process. When an active globulin concentrate was filtered through Berkefeld candles, it lost its in vitro inactivating power. This is not true of convalescent sera in the native state. No tests have, however, been made with globulin concentrates from such sera. The experiments described in this paper raise the question whether, therapeutically considered, the antipoliomyelitic horse serum should be regarded as an exact equivalent of, and hence employed as a perfect substitute for, convalescent serum. This question can only be answered by further experiment and observation. The Rockefeller University Press 1931-01-01 /pmc/articles/PMC2131941/ /pubmed/19869822 Text en Copyright © Copyright, 1931, by The Rockefeller Institute for Medical Research New York This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Rhoads, C. P.
EXPERIMENTAL STUDY OF A HORSE ANTIPOLIOMYELITIC SERUM
title EXPERIMENTAL STUDY OF A HORSE ANTIPOLIOMYELITIC SERUM
title_full EXPERIMENTAL STUDY OF A HORSE ANTIPOLIOMYELITIC SERUM
title_fullStr EXPERIMENTAL STUDY OF A HORSE ANTIPOLIOMYELITIC SERUM
title_full_unstemmed EXPERIMENTAL STUDY OF A HORSE ANTIPOLIOMYELITIC SERUM
title_short EXPERIMENTAL STUDY OF A HORSE ANTIPOLIOMYELITIC SERUM
title_sort experimental study of a horse antipoliomyelitic serum
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2131941/
https://www.ncbi.nlm.nih.gov/pubmed/19869822
work_keys_str_mv AT rhoadscp experimentalstudyofahorseantipoliomyeliticserum